Hongliang Zong



Education Background:

Bachelor in Medicine, Ph.D. in Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University


Dr. Hongliang Zong has research experience in oncology and immunology for over 20 years, and has published more than 40 SCI papers, book chapters and several patents. Dr. Zong has been focusing on process development, quality management and clinical trials of immune cell therapy products targeting solid tumors. Prior to joining Neukio, he served as research associate at Weill Cornell Medical College, the Chief Scientific Officer of Tofflon Healthcare, and the General Manager of Exuma Biotechnology where he successfully completed process development and validation, and manufactured hundreds of autologous CAR-T cell preparations for clinical studies.